Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
335K
-
Shares change
-
-209K
-
Total reported value, excl. options
-
$1.9M
-
Value change
-
-$1.48M
-
Put/Call ratio
-
0.29
-
Number of buys
-
5
-
Number of sells
-
-6
-
Price
-
$5.68
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q2 2015
20 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q2 2015.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 335K shares
of 41M outstanding shares and own 0.82% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (212K shares), GREYLIN INVESTMENT MANGEMENT INC (45.1K shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (40K shares), HSBC HOLDINGS PLC (15K shares), WELLS FARGO & COMPANY/MN (6.5K shares), MORGAN STANLEY (4.52K shares), FineMark National Bank & Trust (3.47K shares), UBS Group AG (3.4K shares), PNC Financial Services Group, Inc. (2.72K shares), and LADENBURG THALMANN FINANCIAL SERVICES INC (1K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.